Published in Oncology Business Week, May 27th, 2007
"We evaluated the activity of the following schedule: weekly DTX 30 mg/m2 iv, daily EMP 10mg/kg po, and CBDCA AUC=6 iv on day 1 of a every 4-wk cycle. Treatment was continued until disease progression or excessive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week